Salmon calcitonin therapy for paget's disease of bone the problem of acquired clinical resistance
The DOI matches its Crossref record.
Abstract
During the initial months of long‐term treatment of Paget's disease of bone with salmon calcitonin, circulating alkaline phosphatase activity and urinary hydroxyproproline excretion usually decrease by about 50%. In 22 of 85 patients these parameters returned to pretreatment levels despite continuous therapy. Nineteen patients who were resistant to salmon calcitonin had salmon calcitonin antibodies in high titer. Human calcitonin has been effective in suppressing disease activity in these patients. The pathogenesis of calcitonin resistance in patients without antibodies is unknown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Management of Paget's Disease of Bone
Delmas, P. D., & Meunier, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360807 · Cited by 277
Takahashi, S., Goldring, S., Katz, M., Hilsenbeck, S., Williams, R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117634 · Cited by 125
Calcitonin Receptor Plays a Physiological Role to Protect Against Hypercalcemia in Mice
Davey, R. A., Turner, A. G., McManus, J. F., Chiu, W. M., Tjahyono, F., Moore, A. J., Atkins, G. J., Anderson, P. H., Ma, C., Glatt, V., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080310 · Cited by 87
“The use of calcitonin as a therapeutic agent in the treatment of hypercalcemia and bone disease has been severely limited by calcitonin’s short duration of action.((5,6))”
BackgroundTurner, A. G., Tjahyono, F., Chiu, W. S. M., Skinner, J., Sawyer, R., Moore, A. J., Morris, H. A., Findlay, D. M., Zajac, J. D., & Davey, R. A. (2011) · Bone · doi:10.1016/j.bone.2010.09.013 · Cited by 39
Metadata
- Authors
- Singer, F. R., Fredericks, R. S., & Minkin, C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1980-10
- Volume
- 23
- Issue
- 10
- Pages
- 1148-1154
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2009596858
- Cited by
- 119
- References
- 0
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salmon calcitonin therapy for paget's disease of bone the problem of acquired clinical resistance. https://app.cochat.ai/papers/10.1002/art.1780231012
- The paper
- Singer, F. R., Fredericks, R. S., & Minkin, C. (1980). Salmon calcitonin therapy for paget's disease of bone the problem of acquired clinical resistance. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780231012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.